ORPHETAB

This brand name is authorized in Nigeria.

Active ingredients

The drug ORPHETAB contains one active pharmaceutical ingredient (API):

1	Orphenadrine UNII X0A40N8I4S - ORPHENADRINE CITRATE
	Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism.
	Read more about Orphenadrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4162	Tablet	ORPHETAB TABLET 100MG TAB 100 mg 10 x10,2x10	57 RNW-PP-347630 ORPHETAB TABLET 100MG OPHENADRINE CITIRTE Orphenadrine citrate 100mg A4-4162 Drugs Nigerian Products 10 x10,2x10 Prescription Only Medicine (POM) 9/26/2023 LAIDER INTERNATIONAL W.A. LTD, 16B,SEHINDE CALLISTO OSHODI 17945374 layiabidoye@yahoo.com ECOMED PHARMA LIMITED., PLOT 32, LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESS WAY, SANGO OTTA., Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03BC01	Orphenadrine (citrate)	M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BC Ethers, chemically close to antihistamines
Discover more medicines within M03BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4162